Half of COPD patients misdiagnosed, says survey
June 9, 2006Sales and Marketing
A new survey of patients with chronic obstructive pulmonary disease has found nearly half have been misdiagnosed with asthma, meaning …
Humira gets go-ahead for the treatment of ankylosing spondylitis
June 9, 2006Sales and Marketing
Abbott has been given the green light to market Humira in Europe for the treatment of severe active ankylosing spondylitis.This …
China upholds Viagra patent
June 6, 2006Sales and Marketing
A Chinese court has come down on the side of Pfizer in the pharma company's battle to prevent local companies …
Avastin filed for advanced breast cancer
June 5, 2006Sales and Marketing
Roche and Genentech have filed Avastin in the US for first-line treatment of women with metastatic breast cancer.The drug has …
European agreement to improve children’s medicines
June 2, 2006Sales and Marketing
It will soon be easier for pharma companies to develop medicines specifically for children, after the European Parliament approved a …
OTC regulations to be streamlined
June 2, 2006Sales and Marketing
The rules governing the way over-the-counter medicines are regulated are set to change as the government strives to reduce the …
Practice ‘clusters’ urged to lead next phase of NHS revolution
June 2, 2006England's general practices are being urged to seize their opportunity to re-build the NHS as a primary care-led, patient-centred service, …
Outrage over NICE verdict on Alzheimer’s drugs
June 1, 2006Sales and Marketing
Hundreds of thousands of patients with early or late-onset Alzheimer's disease (AD) are to be denied access to four drugs …
Roundhouse joins Affiniti marketing communications group
May 30, 2006Medical Communications
Adventis, the multimedia marketing group has bought healthcare advertising agency Roundhouse for 1.6 million pounds as part of its expansion …
First private contractors to provide GP services
May 30, 2006Care UK has signed a contract to provide GP services in Barking and Dagenham, making it the first private company …
PCT mergers bring end to uncertainty
May 30, 2006The number of Primary Care Trusts in England is to be cut in half from 303 to just 152, the …
GSK investors opt for anonymity in face of animal extremist threat
May 30, 2006Sales and Marketing
GlaxoSmithKline shareholders are using an administrative loophole to protect themselves in the face of a threatening letter campaign by animal …
Acomplia poised for approval as NHS focuses on fighting fat
May 30, 2006Sales and Marketing
Acomplia, the first-of-a-kind weight-loss drug, is set to gain approval across Europe within the coming weeks, offering a new hope …
NICE set to recommend new ‘gold standard’ treatments for early-stage breast cancer
May 30, 2006Three early breast cancer drugs are a step closer to overtaking the current gold standard treatment, after preliminary recommendation from …
Ringing the changes in pharmaceutical sales
May 25, 2006Sales and Marketing
Every business and every market is unique, but there is a huge expanse of common ground when it comes to …
Pharmacists given new guidance on counterfeit medicines
May 24, 2006Manufacturing and Production
Pharmacists have been asked to keep an eye out for suspected counterfeit medicines as part of a new awareness-raising initiative.Pharmacists' …
Pfizer’s insomnia treatment hit by ruling
May 24, 2006Sales and Marketing
A new insomnia treatment developed by Pfizer and Neurocrine Biosciences has suffered a setback after US regulators said a high-dose …
Phytopharm looks for licensing partner for Alzheimer drug
May 24, 2006Research and Development
Specialist pharma company Phytopharm says it is confident of finding a partner to develop and market one of its lead …
Exelon is first drug for Parkinson’s disease dementia
May 24, 2006Research and Development
Exelon has been launched as the first ever treatment for mild to moderately severe dementia associated with idiopathic Parkinson's disease.The …
PCTs hiding behind NICE decision over drug, says blindness charity
May 22, 2006A UK blindness charity says patients are being denied a new drug because PCTs are exploiting a delay in NICE's …
Latest content
FibroFind appoints Lee Borthwick as CEO
